VP16 Serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo

Παρόμοια τεκμήρια

• De Novo Synthesis of VP16 Coordinates the Exit from HSV Latency In Vivo
  ανά: Thompson, Richard L., κ.ά.
  Έκδοση: (2009)
• Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency
  ανά: Thompson, Richard L, κ.ά.
  Έκδοση: (2010)
• Targeted Promoter Replacement Reveals That Herpes Simplex Virus Type-1 and 2 Specific VP16 Promoters Direct Distinct Rates of Entry Into the Lytic Program in Sensory Neurons in vivo
  ανά: Thompson, Richard L., κ.ά.
  Έκδοση: (2019)
• The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency.
  ανά: Thompson, R L, κ.ά.
  Έκδοση: (1997)
• Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency
  ανά: Thellman, Nikki M., κ.ά.
  Έκδοση: (2017)